{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:34:25Z","timestamp":1764905665842},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s40266-016-0417-7","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T08:13:18Z","timestamp":1478679198000},"page":"839-840","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["ACE Inhibitors and Sarcopenia: Covering All the BASEs?"],"prefix":"10.1007","volume":"33","author":[{"given":"Jochen","family":"Springer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"issue":"4","key":"417_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","volume":"5","author":"JE Morley","year":"2014","unstructured":"Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):253\u20139.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"2","key":"417_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ageing\/afs194","volume":"42","author":"F Landi","year":"2013","unstructured":"Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80\u00a0years and older: results from ilSIRENTE study. Age Ageing. 2013;42(2):203\u20139.","journal-title":"Age Ageing."},{"issue":"3","key":"417_CR3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290\u20138.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"3","key":"417_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0838.1995.tb00026.x","volume":"5","author":"MM Porter","year":"1995","unstructured":"Porter MM, Vandervoort AA, Lexell J. Aging of human muscle: structure, function and adaptability. Scand J Med Sci Sports. 1995;5(3):129\u201342.","journal-title":"Scand J Med Sci Sports."},{"issue":"9363","key":"417_CR5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077\u201383.","journal-title":"Lancet."},{"issue":"3","key":"417_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1113\/expphysiol.2014.084095","volume":"100","author":"T Kadoguchi","year":"2015","unstructured":"Kadoguchi T, Kinugawa S, Takada S, et al. Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle. Exp Physiol. 2015;100(3):312\u201322.","journal-title":"Exp Physiol."},{"issue":"5","key":"417_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.114.305393","volume":"117","author":"P Bois Du","year":"2015","unstructured":"Du Bois P, Pablo Tortola C, Lodka D, et al. Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression. Circ Res. 2015;117(5):424\u201336.","journal-title":"Circ Res."},{"issue":"3","key":"417_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13539-014-0133-2","volume":"5","author":"SA Cichello","year":"2014","unstructured":"Cichello SA, Weisinger RS, Schuijers J, et al. 1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model. J Cachexia Sarcopenia Muscle. 2014;5(3):239\u201346.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"417_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0396-8","author":"D Spira","year":"2016","unstructured":"Spira D, Walston J, Buchmann N, et al. ACE inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the Berlin Aging Study II (BASE-II). Drugs Aging. 2016. doi: 10.1007\/s40266-016-0396-8 .","journal-title":"Drugs Aging"},{"issue":"9","key":"417_CR10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40266-015-0288-3","volume":"32","author":"LS Zhou","year":"2015","unstructured":"Zhou LS, Xu LJ, Wang XQ, et al. Effect of angiotensin-converting enzyme inhibitors on physical function in elderly subjects: a systematic review and meta-analysis. Drugs Aging. 2015;32(9):727\u201335.","journal-title":"Drugs Aging."},{"issue":"5","key":"417_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ageing\/afu008","volume":"43","author":"MD Witham","year":"2014","unstructured":"Witham MD, Syddall HE, Dennison E, et al. ACE inhibitors, statins and thiazides: no association with change in grip strength among community dwelling older men and women from the Hertfordshire Cohort Study. Age Ageing. 2014;43(5):661\u20136.","journal-title":"Age Ageing."},{"issue":"2","key":"417_CR12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1589\/jpts.28.547","volume":"28","author":"VA Coelho","year":"2016","unstructured":"Coelho VA, Probst VS, Nogari BM, et al. Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults. J Phys Ther Sci. 2016;28(2):547\u201352.","journal-title":"J Phys Ther Sci."},{"issue":"2","key":"417_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11357-010-9196-y","volume":"33","author":"CS Carter","year":"2011","unstructured":"Carter CS, Giovannini S, Seo DO, et al. Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 x Brown Norway rats. Age (Dordr). 2011;33(2):167\u201383.","journal-title":"Age (Dordr)."},{"issue":"4","key":"417_CR14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11357-012-9428-4","volume":"35","author":"E Marzetti","year":"2013","unstructured":"Marzetti E, Calvani R, DuPree J, et al. Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle. Age (Dordr). 2013;35(4):1061\u201375.","journal-title":"Age (Dordr)."},{"issue":"9","key":"417_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S0100-879X2010007500088","volume":"43","author":"T Fernandes","year":"2010","unstructured":"Fernandes T, Hashimoto NY, Oliveira EM. Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats. Braz J Med Biol Res. 2010;43(9):837\u201342.","journal-title":"Braz J Med Biol Res."},{"issue":"7","key":"417_CR16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009;32(7):533\u20136.","journal-title":"Hypertens Res."},{"issue":"4","key":"417_CR17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","volume":"47","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Ohishi M, Katsuya T, et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension. 2006;47(4):718\u201326.","journal-title":"Hypertension."},{"key":"417_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.10.022","volume":"51","author":"O Echeverria-Rodriguez","year":"2014","unstructured":"Echeverria-Rodriguez O, Del Valle-Mondragon L, Hong E. Angiotensin 1\u20137 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Peptides. 2014;51:26\u201330.","journal-title":"Peptides."},{"issue":"3","key":"417_CR19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","volume":"32","author":"K Yamada","year":"1998","unstructured":"Yamada K, Iyer SN, Chappell MC, et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension. 1998;32(3):496\u2013502.","journal-title":"Hypertension."},{"issue":"9","key":"417_CR20","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"KD Silveira da","year":"2010","unstructured":"da Silveira KD, Coelho FM, Vieira AT, et al. Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis. J Immunol. 2010;185(9):5569\u201376.","journal-title":"J Immunol."},{"issue":"2","key":"417_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00418-014-1275-1","volume":"143","author":"MG Morales","year":"2015","unstructured":"Morales MG, Abrigo J, Meneses C, et al. Expression of the Mas receptor is upregulated in skeletal muscle wasting. Histochem Cell Biol. 2015;143(2):131\u201341.","journal-title":"Histochem Cell Biol."},{"issue":"4","key":"417_CR22","doi-asserted-by":"crossref","first-page":"R1223","DOI":"10.1152\/ajpregu.00730.2004","volume":"289","author":"CM Westerkamp","year":"2005","unstructured":"Westerkamp CM, Gordon SE. Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R1223\u201331.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"12","key":"417_CR23","doi-asserted-by":"crossref","first-page":"e15212","DOI":"10.1371\/journal.pone.0015212","volume":"5","author":"AP Johnston","year":"2010","unstructured":"Johnston AP, Baker J, Bellamy LM, et al. Regulation of muscle satellite cell activation and chemotaxis by angiotensin II. PLoS One. 2010;5(12):e15212.","journal-title":"PLoS One."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-016-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-016-0417-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-016-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:09:32Z","timestamp":1498360172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-016-0417-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1007\/s40266-016-0417-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}